Weatherall DJ (2010) The inherited diseases of hemoglobin are an emerging global health burden. Blood 115(22):4331–4336
Article CAS PubMed PubMed Central Google Scholar
Modell B, Darlison M (2008) Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ [Internet]. [cited 2018 Dec 24];86(6):480–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18568278
Williams TN, Weatherall DJ (2012) World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harb Perspect Med 2(9):a011692
Article PubMed PubMed Central Google Scholar
Madan N, Sharma S, Sood SK, Colah R, Bhatia HM (2010) Frequency of β-thalassemia trait and other hemoglobinopathies in northern and western India. Indian J Hum Genet 16(1):16–25
Article CAS PubMed PubMed Central Google Scholar
Colah RB, Gorakshakar A (2014) Control of thalassemia in India. Thal Rep 4:16–19
Verma IC, Saxena R, Kohli S (2011) Past, present & future scenario of thalassaemic care & control in India. Indian J Med Res 134:507–521
CAS PubMed PubMed Central Google Scholar
Grow K, Vashist M, Abrol P, Sharma S, Yadav R (2014) Beta thalassemia in India: Current status and challenges ahead. Int J Pharm Pharm Sci 6:28–33
Mohanty D, Colah RB, Gorakshakar AC, Patel R, Master D, Mahanta J et al (2013) Prevalence of β -thalassemia and other haemoglobinopathies in six cities in India : a multicentre study. J Community Genet 4:33–42
Article CAS PubMed Google Scholar
Management of hemoglobin disorders, Report of Joint WHO-TIF meeting, Nicosia, Cyprus, 16–18 November, 2007. Geneva: WHO; 2008. World Health Organization
Old JM (2003) Screening and genetic diagnosis of haemoglobin disorders. Blood Rev 17(1):43–53
Article CAS PubMed Google Scholar
Batanian JR, Ledbetter DH, Fenwick RG (1998) A simple VNTR-PCR method for detecting maternal cell contamination in prenatal diagnosis. Genet Test 2(4):347–350
Article CAS PubMed Google Scholar
Mendiratta SL, Bajaj S, Popli S, Singh S (2015) Screening of women in the antenatal period for thalassemia carrier status: comparison of NESTROFT, red cell indices, and HPLC analysis. J Fetal Med 2(1):21–25
Colah R, Surve R, Wadia M, Solanki P, Mayekar P, Thomas M et al (2008) Carrier screening for β-Thalassemia during pregnancy in India: A 7-year evaluation. Genet Test 12(2):181–185
Mohanty D, Colah R, Gorakshakar A (eds) (2008) Jai Vigyan S & T Mission Project on Community Control of Thalassemia Syndromes- Awareness, Screening, Genetic Counseling and Prevention. Director General, Indian Council of Medical Research, New Delhi
Mendiratta SL, Mittal M, Naaz F, Singh S, Anand S (2016) Role of thalassemia screening in prevention and control of thalassemia - a 5 year experience. Int J Reprod Contracept Obstet Gynecol 5(9):3107–11
Sharma A, Uppal N, Kukreja S, Kaur M, Kaur S (2020) Screening of thalassemia in pregnant females visiting tertiary hospital in Amritsar. Int J Clin Biochem Res 7:226–231
Narang V, Jain A, Grover S, Soni A, Narang M, Taneja A (2023) Prevalence and spectrum of haemoglobinopathies in females of reproductive age group- a first tertiary care center experience in Punjab, North India. Indian J Pathol Microbiol 66:564–567
Das R (2012) Micro mapping the frequencies of beta thalassemia and sickle cell anemia in India: a way forward to plan control strategies. Indian J Hum Genet 18(2):148–149
Article PubMed PubMed Central Google Scholar
Sharma P, Das R, Trehan A, Bansal D, Chhabra S, Kaur J et al (2015) Impact of iron deficiency on hemoglobin A2% in obligate β-thalassemia heterozygotes. Int J Lab Hematol 37(1):105–111
Rangan A, Sharma P, Dadu T, Saxena R, Verma IC, Bhargava M (2011) β-Thalassemia mutations in subjects with borderline HbA2 values: a pilot study in North India. Clin Chem Lab Med 49(12):2069–2072
Article CAS PubMed Google Scholar
Hariharan P, Colaco S, Colah R, Ghosh K, Nadkarni A (2016) Delta globin gene variations leading to reduction in HbA 2 levels. Int J Lab Hematol [Internet]. [cited 2018 Mar 7];38(6):610–5
Giambona A, Passarello C, Renda D, Maggio A (2009) The significance of the hemoglobin A2 value in screening for hemoglobinopathies. Clin Biochem [Internet]. [cited 2018 Mar 7];42(18):1786–96
Mosca A, Paleari R, Galanello R, Sollaino C, Perseu L, Demartis FR et al (2008) New analytical tools and epidemiological data for the identification of HbA2 borderline subjects in the screening for beta-thalassemia. Bioelectrochemistry 73(2):137–140
Article CAS PubMed Google Scholar
Munkongdee T, Tanakulmas J, Butthep P, Winichagoon P, Main B, Yiannakis M et al (2016) Molecular Epidemiology of Hemoglobinopathies in Cambodia. Hemoglobin [Internet]. [cited 2018 Dec 22];40(3):163–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27117566
Lee A, Wong K, So K, Cheng M (1998) Why are thalassemia patients born when prenatal screening is available? Hong Kong Med J 4:121–124
Comments (0)